Maxef

(Ceftriaxone)

Composition:

Vials containing dry substance equivalent to 250mg, 500mg, 1g Ceftriaxone.

Indications:

Infections caused by pathogens sensitive to Maxef (Ceftriaxone), e.g.: sepsis,meningitis; abdominal infections (Peritonitis, infections of the biliary and gastrointestinal tracts); infections of the bones, joints, soft tissue, skin and of wounds; infections in patients with impaired defence mechanisms; renal and urinary tract infections; respiratory tract infections, particularly pneumonia, and ear, nose and throat infections; genital infections, including gonorrhea. preoperative prophylaxis of infections.

Availabilty:

Maxef I.M. injection containing:

1 vial with sterile ceftriaxone sodium U.S.P. equivalent to 250mg, 500mg and 1g ceftriaxone, and 1 ampoule 2ml & 3.5ml of 1 % w/v Lignocaine Hydrochloride solution.

Maxef I.V. injection containing:

1 vial with sterile ceftriaxone sodium U.S.P. equivalent to 250mg, 500mg and 1g ceftriaxone, and 1 ampoule 5ml & 10ml of sterile Water for injection.